腺苷
缺血
腺苷受体
医学
肾
肾缺血
腺苷A1受体
缺血预处理
腺苷A3受体
兴奋剂
再灌注损伤
肾功能
腺苷受体拮抗剂
内科学
药理学
麻醉
内分泌学
受体
作者
H. Thomas Lee,Charles W. Emala
出处
期刊:American Journal of Physiology-renal Physiology
[American Physiological Society]
日期:2000-03-01
卷期号:278 (3): F380-F387
被引量:232
标识
DOI:10.1152/ajprenal.2000.278.3.f380
摘要
Renal ischemia and reperfusion during aortic and renal transplant surgery result in ischemic-reperfusion injury. Ischemic preconditioning and adenosine infusion before ischemia protect against ischemic-reperfusion injury in cardiac and skeletal muscle, but these protective phenomena have not been demonstrated in the kidney. Rats were randomized to sham operation, 45-min renal ischemia, ischemic preconditioning with four cycles of 8-min renal ischemia and 5-min reperfusion followed by 45-min renal ischemia, systemic adenosine pretreatment before 45-min renal ischemia, or pretreatments with selective adenosine receptor subtype agonists or antagonists before 45-min renal ischemia. Forty-five minutes of renal ischemia followed by 24 h of reperfusion resulted in marked rises in blood urea nitrogen and creatinine. Ischemic preconditioning and adenosine pretreatment protected renal function and improved renal morphology. A 1 adenosine receptor activation mimics and A 1 adenosine antagonism blocks adenosine-induced protection. In addition, A 3 adenosine receptor activation before renal ischemia worsens renal ischemic-reperfusion injury, and A 3 adenosine receptor antagonism protects renal function. We demonstrate for the first time that rat kidneys can be preconditioned to attenuate ischemic-reperfusion injury and adenosine infusion before ischemic insult protects renal function via A 1 adenosine receptor activation. Our data suggest that an A 1 adenosine agonist and A 3 adenosine antagonist may have clinically beneficial implications where renal ischemia is unavoidable.
科研通智能强力驱动
Strongly Powered by AbleSci AI